MeSH term
Frequency | Condition_Probility | Animals | 84 | 0.0 |
Antigens, CD/chemistry/genetics/*metabolism | 2 | 6.0 |
Blotting, Western | 20 | 0.0 |
Cloning, Molecular | 17 | 0.0 |
Glycosylation | 7 | 0.0 |
Humans | 229 | 0.0 |
Male | 55 | 0.0 |
Membrane Glycoproteins/chemistry/genetics/*metabolism | 2 | 8.0 |
Mice | 30 | 0.0 |
Mice, Transgenic | 6 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 43 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Spermatozoa/*metabolism | 2 | 3.0 |
Testis/metabolism | 6 | 2.0 |
Mutation | 2 | 0.0 |
Complement 3b/*metabolism | 6 | 6.0 |
Complement 4b/*metabolism | 2 | 11.0 |
Complement 5/metabolism | 2 | 4.0 |
Complement Inactivators/physiology | 5 | 71.0 |
Complement Pathway, Alternative | 5 | 4.0 |
Dose-Response Relationship, Immunologic | 4 | 0.0 |
Hamsters | 17 | 0.0 |
Hydrolysis | 2 | 0.0 |
Membrane Proteins/metabolism | 4 | 0.0 |
Peptide Fragments/metabolism | 3 | 0.0 |
Protein Binding/immunology | 2 | 1.0 |
Transfection | 18 | 0.0 |
Antigens, CD/metabolism | 8 | 0.0 |
Antigens, CD55/metabolism | 6 | 19.0 |
Antigens, CD59/metabolism | 7 | 21.0 |
Cell Differentiation | 4 | 0.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Complement 3d/metabolism | 2 | 9.0 |
Complement Inactivators/*metabolism | 12 | 34.0 |
Complement Membrane Attack Complex/metabolism | 2 | 5.0 |
Membrane Glycoproteins/metabolism | 7 | 1.0 |
Microscopy, Immunoelectron | 5 | 0.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Antigens, CD/*genetics/immunology | 2 | 11.0 |
Antigens, CD55/*genetics/immunology | 2 | 28.0 |
Base Sequence | 33 | 0.0 |
Complement/*physiology | 8 | 9.0 |
DNA Primers | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 8 | 0.0 |
Gene Transfer Techniques | 2 | 0.0 |
Membrane Glycoproteins/*genetics/immunology | 3 | 15.0 |
Polymerase Chain Reaction | 12 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Swine | 14 | 1.0 |
Adult | 29 | 0.0 |
Aged | 14 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Cytokines/*metabolism | 2 | 0.0 |
Female | 54 | 0.0 |
Immunoenzyme Techniques | 10 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Middle Aged | 23 | 0.0 |
Monocyte Chemoattractant Proteins/metabolism | 2 | 22.0 |
Research Support, Non-U.S. Gov't | 161 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Antigens, CD/*metabolism | 12 | 1.0 |
Complement Inactivators/metabolism | 3 | 15.0 |
Membrane Glycoproteins/*metabolism | 16 | 3.0 |
CHO Cells | 15 | 0.0 |
Flow Cytometry | 24 | 0.0 |
Antigens, CD55/*metabolism | 7 | 23.0 |
Cells, Cultured | 17 | 0.0 |
Up-Regulation | 6 | 0.0 |
3T3 Cells | 4 | 0.0 |
Antigens, CD/genetics/*metabolism | 6 | 6.0 |
Antigens, CD55/genetics/*metabolism | 2 | 25.0 |
Complement/*immunology | 10 | 7.0 |
*Cytotoxicity, Immunologic | 5 | 1.0 |
Guinea Pigs | 9 | 1.0 |
Membrane Glycoproteins/genetics/*metabolism | 6 | 3.0 |
Rabbits | 6 | 0.0 |
Species Specificity | 10 | 0.0 |
Transplantation, Heterologous | 4 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cytokines/genetics/*metabolism | 2 | 5.0 |
Gene Expression | 9 | 0.0 |
Chronic Disease | 4 | 0.0 |
Antigens, CD/*biosynthesis/genetics | 2 | 3.0 |
Membrane Glycoproteins/*biosynthesis/genetics | 2 | 3.0 |
Tissue Distribution | 5 | 0.0 |
Comparative Study | 23 | 0.0 |
Complement/*metabolism | 11 | 6.0 |
Complement Activation | 9 | 3.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Rats | 13 | 0.0 |
Receptors, Complement/metabolism | 5 | 8.0 |
Receptors, Complement 3b/metabolism | 2 | 9.0 |
Adolescent | 6 | 0.0 |
Case-Control Studies | 5 | 0.0 |
Pregnancy | 6 | 0.0 |
Risk Factors | 4 | 0.0 |
Antigens, CD/chemistry/*metabolism | 2 | 5.0 |
Complement 3b/metabolism | 7 | 6.0 |
Membrane Glycoproteins/chemistry/*metabolism | 2 | 6.0 |
Antigens, CD/*physiology | 4 | 1.0 |
Jurkat Cells | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 5 | 1.0 |
Phosphorylation | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Monocyte Chemoattractant Protein-1/metabolism | 2 | 3.0 |
Phytohemagglutinins/pharmacology | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Animals, Genetically Modified | 3 | 1.0 |
*Antigens, CD | 29 | 3.0 |
Graft Rejection | 2 | 1.0 |
*Membrane Glycoproteins | 4 | 0.0 |
Antigens, CD55/*immunology | 2 | 16.0 |
Antigens, CD55 | 34 | 17.0 |
Antigens, CD59 | 16 | 8.0 |
*Complement Activation | 7 | 1.0 |
Receptors, Complement 3b | 11 | 3.0 |
Chemokines/metabolism | 2 | 2.0 |
Cytokines/metabolism | 2 | 0.0 |
Antigens, CD59/*metabolism | 7 | 19.0 |
Chromatography, Gel | 2 | 0.0 |
Complement Hemolytic Activity Assay | 2 | 4.0 |
Complement Inactivators/*physiology | 5 | 25.0 |
Electrophoresis, Polyacrylamide Gel | 9 | 0.0 |
Immunoblotting | 8 | 0.0 |
Complement Activation/*genetics | 3 | 42.0 |
*Multigene Family | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Chemokines/*pharmacology | 2 | 7.0 |
Time Factors | 3 | 0.0 |
Complement/physiology | 3 | 6.0 |
English Abstract | 7 | 0.0 |
Molecular Weight | 11 | 0.0 |
Antigens, CD/genetics | 2 | 1.0 |
DNA Mutational Analysis | 2 | 0.0 |
Amino Acid Sequence | 30 | 0.0 |
Antibodies, Monoclonal/immunology | 5 | 0.0 |
Binding Sites | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Molecular Sequence Data | 43 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Peptide Fragments/chemistry/metabolism | 2 | 1.0 |
Protein Conformation | 4 | 0.0 |
Antibodies, Monoclonal | 11 | 0.0 |
Complement Activation/*immunology | 3 | 5.0 |
Erythrocytes/immunology | 4 | 1.0 |
Hemolysis/immunology | 3 | 20.0 |
Solubility | 8 | 0.0 |
Cell Line | 22 | 0.0 |
Cytotoxicity, Immunologic | 7 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Transplantation, Heterologous/*immunology | 3 | 5.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
Epithelium/immunology | 5 | 3.0 |
Anti-HIV Agents/*therapeutic use | 2 | 0.0 |
RNA, Viral/blood | 2 | 0.0 |
Reference Values | 6 | 0.0 |
*Alternative Splicing | 3 | 0.0 |
Blotting, Southern | 5 | 0.0 |
Organ Specificity | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Antigens, CD/*genetics | 8 | 3.0 |
Conserved Sequence | 2 | 0.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
Membrane Glycoproteins/*genetics | 10 | 2.0 |
Restriction Mapping | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
*Transplantation, Heterologous | 3 | 4.0 |
Interleukin-8/metabolism | 2 | 1.0 |
In Situ Hybridization | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Immunohistochemistry | 20 | 0.0 |
Cycloheximide/pharmacology | 3 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
Antigens, CD/physiology | 4 | 1.0 |
Antigens, CD59/physiology | 3 | 42.0 |
Membrane Glycoproteins/physiology | 4 | 2.0 |
Antigens, CD/*analysis | 14 | 1.0 |
Complement Inactivators/*analysis | 8 | 27.0 |
Endothelium, Vascular/*immunology | 3 | 3.0 |
Membrane Glycoproteins/*analysis | 14 | 9.0 |
Swine/*immunology | 2 | 6.0 |
Testis/immunology | 3 | 21.0 |
Antigens, CD/*genetics/metabolism | 2 | 4.0 |
Blotting, Northern | 8 | 0.0 |
Complement 3/metabolism | 8 | 3.0 |
Complement Factor I/metabolism | 4 | 44.0 |
Complement Inactivators/*genetics | 4 | 33.0 |
Membrane Glycoproteins/*genetics/metabolism | 2 | 2.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Complement Inactivators/analysis | 3 | 21.0 |
Cell Line, Transformed | 3 | 0.0 |
Complement 3/*metabolism | 4 | 2.0 |
*Complement Pathway, Classical | 2 | 2.0 |
Lectins/metabolism | 2 | 2.0 |
Membrane Glycoproteins/*blood | 2 | 3.0 |
Antigens, CD/immunology | 4 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Complement 9/metabolism | 2 | 6.0 |
Membrane Glycoproteins/immunology | 5 | 2.0 |
Antibodies, Monoclonal/*immunology | 4 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Antigens, CD/*immunology | 6 | 1.0 |
Binding, Competitive | 4 | 0.0 |
Complement Inactivators/*immunology | 3 | 25.0 |
Cross Reactions | 4 | 0.0 |
Dogs | 2 | 0.0 |
Leukocytes/immunology | 2 | 1.0 |
Membrane Glycoproteins/*immunology | 10 | 5.0 |
Interferon Type II/*pharmacology | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Receptors, Complement 3b/*metabolism | 3 | 15.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Antigens, CD/biosynthesis | 3 | 0.0 |
Antigens, CD55/biosynthesis | 2 | 28.0 |
Antigens, CD59/biosynthesis | 2 | 20.0 |
Complement Inactivators/*biosynthesis | 4 | 66.0 |
Membrane Glycoproteins/biosynthesis | 3 | 1.0 |
Membrane Proteins/*biosynthesis | 2 | 3.0 |
Antigens, CD55/physiology | 2 | 50.0 |
Receptors, Complement/physiology | 3 | 15.0 |
Breast/immunology | 2 | 33.0 |
Colorectal Neoplasms/*immunology | 2 | 7.0 |
Complement | 2 | 4.0 |
HLA Antigens/analysis | 2 | 0.0 |
Lymphocytes/immunology | 4 | 1.0 |
Analysis of Variance | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Kinetics | 6 | 0.0 |
Transfection/immunology | 2 | 4.0 |
Antigens, CD55/immunology | 2 | 15.0 |
Antigens, CD59/immunology | 2 | 20.0 |
Epithelial Cells | 3 | 0.0 |
Lung Neoplasms/*immunology | 2 | 4.0 |
Phosphatidylinositol Diacylglycerol-Lyase | 2 | 2.0 |
Tumor Cells, Cultured | 19 | 0.0 |
Antigens, CD55/analysis | 2 | 10.0 |
Antigens, CD59/analysis | 2 | 9.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Intestinal Mucosa/*immunology | 2 | 2.0 |
Membrane Glycoproteins/analysis | 4 | 1.0 |
Alternative Splicing | 2 | 0.0 |
*Molecular Chaperones | 3 | 2.0 |
Cercopithecus aethiops | 6 | 0.0 |
Receptors, Virus/*physiology | 2 | 5.0 |
Vero Cells | 5 | 2.0 |
Fibrinogen/metabolism | 2 | 0.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Graft Rejection/*immunology | 2 | 2.0 |
*Transplantation Immunology | 2 | 4.0 |
Epithelium/metabolism | 2 | 0.0 |
Cytokines/*pharmacology | 3 | 0.0 |
*Receptors, Chemokine | 2 | 2.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
*Cloning, Molecular | 2 | 0.0 |
Cell Cycle/immunology | 2 | 6.0 |
Cytotoxicity, Immunologic/*immunology | 2 | 4.0 |
Membrane Glycoproteins/*analysis/immunology | 2 | 15.0 |
Complement Inactivators/biosynthesis | 2 | 28.0 |
Cell Communication | 2 | 0.0 |
Complement Membrane Attack Complex/*analysis | 2 | 15.0 |
In Vitro | 9 | 0.0 |
Antigens, CD/*biosynthesis | 5 | 2.0 |
Membrane Glycoproteins/*biosynthesis | 5 | 5.0 |
Complement Activation/immunology | 2 | 6.0 |
Antigens, CD/analysis/*physiology | 2 | 7.0 |
Cell Adhesion | 2 | 0.0 |
Membrane Glycoproteins/analysis/*physiology | 2 | 22.0 |
Vasectomy | 2 | 18.0 |
Consensus Sequence | 3 | 0.0 |
Multigene Family | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 4 | 0.0 |
Biopsy | 2 | 0.0 |
Complement 3b/immunology | 2 | 5.0 |
Complement 4b/metabolism | 2 | 8.0 |
Antigens, CD55/*biosynthesis | 2 | 28.0 |
Antigens, CD59/*biosynthesis | 2 | 28.0 |
Complement Activation/*physiology | 2 | 8.0 |
Chromosome Mapping | 4 | 0.0 |
Antigens, CD/*metabolism/physiology | 2 | 25.0 |
Membrane Glycoproteins/*metabolism/physiology | 2 | 13.0 |
Arthus Reaction/immunology | 2 | 100.0 |
Immunophenotyping | 3 | 0.0 |
Serine/chemistry | 2 | 1.0 |
Threonine/chemistry | 2 | 2.0 |
Antigens, Surface/immunology | 2 | 1.0 |
RNA/analysis | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Precipitin Tests | 6 | 0.0 |
Phenotype | 5 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Antigens, CD/analysis | 2 | 0.0 |
Complement 4b/*antagonists & inhibitors | 2 | 100.0 |
Complement Pathway, Classical | 3 | 2.0 |
Membrane Glycoproteins/genetics/*physiology | 2 | 2.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Radioimmunoassay | 2 | 0.0 |
Receptors, Complement 3b/*analysis | 2 | 13.0 |
Semen/*immunology | 3 | 25.0 |
Rosette Formation | 2 | 0.0 |
Antigens, CD/genetics/*immunology | 2 | 5.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Membrane Glycoproteins/genetics/*immunology | 2 | 3.0 |
Pregnancy/*immunology | 4 | 7.0 |
Receptors, Complement/*physiology | 3 | 5.0 |
*Complement Inactivators | 3 | 3.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Complement 3 Convertase/metabolism | 3 | 7.0 |
Evolution | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Complement/immunology | 2 | 2.0 |
Cell Membrane/immunology | 3 | 1.0 |
Detergents | 2 | 1.0 |
Polyethylene Glycols | 2 | 2.0 |
Membrane Glycoproteins/isolation & purification/*metabolism | 2 | 20.0 |
Cell Adhesion Molecules/metabolism | 2 | 0.0 |
Lupus Erythematosus, Systemic/immunology | 2 | 1.0 |
Erythrocytes/metabolism | 2 | 1.0 |
Spermatozoa/immunology | 2 | 11.0 |
Complement 4/*metabolism | 2 | 4.0 |
Methylamines/pharmacology | 2 | 9.0 |
Trophoblasts/*ultrastructure | 2 | 100.0 |
Trophoblasts/immunology | 3 | 9.0 |
Epitopes | 3 | 0.0 |
Complement/*genetics | 2 | 3.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Complement/*analysis | 3 | 1.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Membrane Proteins/analysis | 3 | 2.0 |
Epitopes/immunology | 2 | 0.0 |
*Glycoproteins | 4 | 0.0 |
Semen/immunology | 3 | 20.0 |
Oligonucleotide Probes | 2 | 0.0 |
Complement 3/*immunology | 3 | 4.0 |
Granulocytes/immunology | 2 | 3.0 |
Complement 3/immunology | 2 | 2.0 |
Glycoside Hydrolases | 2 | 7.0 |
DNA/genetics | 4 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Ligands | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
*Antibodies | 2 | 4.0 |
Rabbits/immunology | 2 | 2.0 |
Complement Factor H | 4 | 5.0 |
Complement Factor I | 6 | 28.0 |
*Complement Pathway, Alternative | 4 | 3.0 |
Serine Endopeptidases/*metabolism | 3 | 3.0 |
Cell Membrane/physiology | 2 | 1.0 |
Complement 3/physiology | 2 | 11.0 |
Isoantigens/immunology | 2 | 2.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Pedigree | 3 | 0.0 |
Receptors, Complement/genetics | 2 | 13.0 |
Chromatography, Affinity | 3 | 0.0 |
Peptide Mapping | 2 | 0.0 |
*Complement | 2 | 3.0 |
Macrophage-1 Antigen | 2 | 4.0 |
Seroepidemiologic Studies | 2 | 1.0 |
Antigens, CD/biosynthesis/*genetics | 2 | 7.0 |
